two days, where six individual muscles are positioned in close contact with the eyeball. Second, we investigated the role of the 'target tissue', the eyeball itself, as source of diffusible signals for EOM patterning. Genetic invalidation of the retinoic acid signaling pathway or selective inhibition of the nuclear retinoic acid receptors resulted in a dramatic impairment of muscle splitting. Moreover, the recognition of the final attachment points in the periocular mesenchyme by tendon progenitors was also impaired in a retinoic-acid deficient situation. Finally, using a reporter of retinoic acid signal transduction we demonstrated that a subpopulation of cranial mesenchymal cells, but not the myogenic progenitors themselves, is the cell type responsive to retinoic acid. Taken together, we propose a model in which retinoic acid secretion from the target organ instructs periocular myogenesis and patterning. The toll and EGF pathways are critical for early embryonic patterning, and have great clinical significance for human pathologies. Therefore, we set out to understand how the toll and EGF pathways are linked, and focused our analysis on raf/ras's connection to the toll pathway. We utilized a raf neomorph which truncated the second and third conserved regions of RAF (the negative regulatory domains and kinase site), leaving only the first conserved region, which binds to RAS. We performed anti-dorsal stains on this RAF neomorph, which showed extreme dorsalization of the embryo. We crossed this mutant with a constitutively active toll mutant (i.e. extremely ventralized) which resulted in a partial rescue. As this mutant binds ras tightly, we concluded that RAS was sequestered by RAF away from its normal plasma membrane localisation preventing RAS from acting in a required toll pathway signal transduction step. We propose that RAS is a necessary component of the toll pathway during early embryonic patterning. 
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